
Rob Duboff
Senior ESG Analyst at Bloomberg Intelligence and host of the ESG Currents and Votes & Verdicts podcasts.
4
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Jul 29, 2026
Climate, AI and Other Key Themes for 2H
15:29
15:35
15:50
16:02
20:12

Rob DuboffGUEST
I think last year when the Trump administration came into office, there were a lot of negative headlines.

Rob DuboffGUEST
Whether that was withdrawing from the Paris Climate Agreement, pulling back clean energy tax credits through the so-called One Big Beautiful Bill, or stopping permitting on wind and solar projects, they were putting their fingers on the scale against renewables in favor of fossil fuels.

Rob DuboffGUEST
And it definitely did have an impact, including slowdowns in home solar installations and EV sales, at least in the short term.

Rob DuboffGUEST
Now, I will say, talking to investors at the end of 2025, there was actually this strange subdued optimism that things could only go up.

Eric KaneHOST
what about investment stewardship? There was a lot of concern about regulatory changes there as well.
What Forces Will Drive ESG Markets in 2026
9:28
9:37
9:53

Eric KaneHOST
rob with your focus on shareholder activism and engagement in the u.s what should we expect in the year ahead

Rob Du BoffGUEST
So 2026, we actually expect to see major challenges to shareholder proposals and corporate engagement.

Rob Du BoffGUEST
And that drop was particularly noteworthy for ESG issues like human rights, which were down 41% from the prior year.
Navigating Noise, Regulation, Risks in Late 2025
31:01
31:10
31:15
31:25
31:35
31:46

Eric KaneHOST
Curious to hear from you, what regulatory changes have we seen in the early days of the new administration and what do we expect going forward?

Rob Du BoffGUEST
Well, the changes have really come fast and furious since the inauguration in January.

Rob Du BoffGUEST
For purposes of this discussion, I'm going to set aside the one big beautiful bill, which we know is going to slow a lot of decarbonization investments through rollbacks on clean energy credits.

Rob Du BoffGUEST
I really just want to focus on changes that may impact how investors are able to actually integrate ESG analysis into the process.

Rob Du BoffGUEST
The current SEC leadership withdrew support for previously issued climate disclosure rules, which required companies to disclose both the financial impacts and the greenhouse gas emissions.

Rob Du BoffGUEST
So without required disclosures, U.S. investors basically have to rely on voluntary disclosures, and those tend to be both inconsistent and incomplete, especially when you look at other developed markets like Europe.
Unpacking the ESG Landscape in Trump’s Second Term
3:30
3:41
4:04
4:13
32:29

Gail GlazermanHOST
And I'm just wondering what you are seeing and how you think companies are responding.

Rob Du BoffGUEST
I would say there was an executive order that came within the first day of the administration, basically not only banning quote-unquote illegal DEI at the government level and across contractors, but also kind of tasking all the agencies to work with the Department of Justice to identify potential enforcement actions.

Rob Du BoffGUEST
So really, it's not just about government service, which it was in the first administration.

Rob Du BoffGUEST
Now, the rub there is that the executive order called out illegal dei which it doesn't really define what that is that you know it reminds me of those drug commercials you see where it's you know don't take if allergic and obviously you shouldn't take if it's allergic but also how would you know if you're allergic if you've never taken it before so it's it's um because it's so vague you have um companies are now just very I guess timid is the right word.
28 MINS LATER

Gail GlazermanHOST
And Rob, can you talk a little bit about what you're seeing on the governance regulation side, anything in terms of shareholder rights engagement?